Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for Northwest Biotherapeutics (NWBO) over the last 15 years, with Q3 2025 value amounting to $475000.0.

  • Northwest Biotherapeutics' Long-Term Debt Repayments fell 1379.31% to $475000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5820.36%. This contributed to the annual value of $1.1 million for FY2024, which is 18831.17% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Long-Term Debt Repayments of $475000.0 as of Q3 2025, which was down 1379.31% from $536000.0 recorded in Q1 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments peaked at $4.0 million during Q1 2022, and registered a low of $2000.0 during Q3 2023.
  • Moreover, its 5-year median value for Long-Term Debt Repayments was $392500.0 (2024), whereas its average is $909928.6.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Long-Term Debt Repayments plummeted by 9800.0% in 2023, and later soared by 2745000.0% in 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments (Quarter) stood at $3.8 million in 2021, then plummeted by 97.41% to $99000.0 in 2022, then soared by 76.77% to $175000.0 in 2023, then soared by 77.14% to $310000.0 in 2024, then skyrocketed by 53.23% to $475000.0 in 2025.
  • Its Long-Term Debt Repayments stands at $475000.0 for Q3 2025, versus $536000.0 for Q1 2025 and $310000.0 for Q4 2024.